Jamison Private Wealth Management, Inc. Moderna, Inc. Transaction History
Jamison Private Wealth Management, Inc.
- $657 Billion
- Q3 2024
A detailed history of Jamison Private Wealth Management, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Jamison Private Wealth Management, Inc. holds 334 shares of MRNA stock, worth $13,503. This represents 0.0% of its overall portfolio holdings.
Number of Shares
334
Previous 374
10.7%
Holding current value
$13,503
Previous $44.4 Million
49.74%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding MRNA
# of Institutions
953Shares Held
240MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.72 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.63 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.03 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$681 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$292 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...